FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Khan Nasser
2. Date of Event Requiring Statement (Month/Day/Year)
06/30/2024		 3. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ACHC]
(Last)
(First)
(Middle)
ACADIA HEALTHCARE COMPANY, INC., 6100 TOWER CIRCLE, SUITE 1000		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Operating Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)

FRANKLIN, TN 37067		 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 26,681 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(Month/Day/Year) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option 03/01/2025(2) 03/01/2033 Common Stock 2,025 $ 72.51 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Khan Nasser
ACADIA HEALTHCARE COMPANY, INC.
6100 TOWER CIRCLE, SUITE 1000
FRANKLIN, TN 37067		       Chief Operating Officer  

Signatures

/s/ Brian Farley as Attorney in Fact for Nasser Khan 07/01/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) 9,000 shares will vest over a 3-year period in equal yearly installments beginning September 30, 2024, 1,800 shares will vest over a 3-year period in equal yearly installments beginning March 1, 2025, 5,000 shares will vest over a 4-year period in equal yearly installments beginning November 7, 2024, 4,997 shares will vest over a 3-year period in equal yearly installments beginning March 29, 2025, and 5,884 shares will vest over a 3-year period in equal yearly installments beginning June 26, 2025.
(2) The options will vest over a 3-year period in equal yearly installments beginning March 1, 2025.
 
Remarks:
Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.